Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial (Q34467911)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial (English)

1 reference

Europe PubMed Central

2 August 2017

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

16

object named as

Amir Lerman

1 reference

Europe PubMed Central

2 August 2017

Stephen G. Ellis

6

object named as

Stephen G Ellis

1 reference

Europe PubMed Central

2 August 2017

1

1 reference

Europe PubMed Central

29 June 2022

Eileen M Handberg

28

object named as

Eileen Handberg

1 reference

Europe PubMed Central

2 August 2017

author name string

Timothy D Henry

2

1 reference

Europe PubMed Central

2 August 2017

Carl J Pepine

3

1 reference

Europe PubMed Central

2 August 2017

James T Willerson

4

1 reference

Europe PubMed Central

2 August 2017

David X M Zhao

5

1 reference

Europe PubMed Central

2 August 2017

John R Forder

7

1 reference

Europe PubMed Central

2 August 2017

R David Anderson

8

1 reference

Europe PubMed Central

2 August 2017

Antonis K Hatzopoulos

9

1 reference

Europe PubMed Central

2 August 2017

Marc S Penn

10

1 reference

Europe PubMed Central

2 August 2017

Emerson C Perin

11

1 reference

Europe PubMed Central

2 August 2017

Jeffrey Chambers

12

1 reference

Europe PubMed Central

2 August 2017

Kenneth W Baran

13

1 reference

Europe PubMed Central

2 August 2017

Ganesh Raveendran

14

1 reference

Europe PubMed Central

2 August 2017

Charles Lambert

15

1 reference

Europe PubMed Central

2 August 2017

Daniel I Simon

17

1 reference

Europe PubMed Central

2 August 2017

Douglas E Vaughan

18

1 reference

Europe PubMed Central

2 August 2017

Dejian Lai

19

1 reference

Europe PubMed Central

2 August 2017

Adrian P Gee

20

1 reference

Europe PubMed Central

2 August 2017

Doris A Taylor

21

1 reference

Europe PubMed Central

2 August 2017

Christopher R Cogle

22

1 reference

Europe PubMed Central

2 August 2017

James D Thomas

23

1 reference

Europe PubMed Central

2 August 2017

Rachel E Olson

24

1 reference

Europe PubMed Central

2 August 2017

Sherry Bowman

25

1 reference

Europe PubMed Central

2 August 2017

Judy Francescon

26

1 reference

Europe PubMed Central

2 August 2017

Carrie Geither

27

1 reference

Europe PubMed Central

2 August 2017

Casey Kappenman

29

1 reference

Europe PubMed Central

2 August 2017

Lynette Westbrook

30

1 reference

Europe PubMed Central

2 August 2017

Linda B Piller

31

1 reference

Europe PubMed Central

2 August 2017

Lara M Simpson

32

1 reference

Europe PubMed Central

2 August 2017

Sarah Baraniuk

33

1 reference

Europe PubMed Central

2 August 2017

Catalin Loghin

34

1 reference

Europe PubMed Central

2 August 2017

David Aguilar

35

1 reference

Europe PubMed Central

2 August 2017

Sara Richman

36

1 reference

Europe PubMed Central

2 August 2017

Claudia Zierold

37

1 reference

Europe PubMed Central

2 August 2017

Daniel B Spoon

38

1 reference

Europe PubMed Central

2 August 2017

Judy Bettencourt

39

1 reference

Europe PubMed Central

2 August 2017

Shelly L Sayre

40

1 reference

Europe PubMed Central

2 August 2017

Rachel W Vojvodic

41

1 reference

Europe PubMed Central

2 August 2017

Sonia I Skarlatos

42

1 reference

Europe PubMed Central

2 August 2017

David J Gordon

43

1 reference

Europe PubMed Central

2 August 2017

Ray F Ebert

44

1 reference

Europe PubMed Central

2 August 2017

Minjung Kwak

45

1 reference

Europe PubMed Central

2 August 2017

Lemuel A Moyé

46

1 reference

Europe PubMed Central

2 August 2017

Robert D Simari

47

1 reference

Europe PubMed Central

2 August 2017

Cardiovascular Cell Therapy Research Network (CCTRN)

48

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

1 December 2012

1 reference

Europe PubMed Central

2 August 2017

The Journal of the American Medical Association

1 reference

Europe PubMed Central

2 August 2017

308

1 reference

Europe PubMed Central

2 August 2017

22

1 reference

Europe PubMed Central

2 August 2017

2380-2389

1 reference

Europe PubMed Central

2 August 2017

Heparin disrupts the CXCR4/SDF-1 axis and impairs the functional capacity of bone marrow-derived mononuclear cells used for cardiovascular repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Stem cell treatment for acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Donor Myocardial Infarction Impairs the Therapeutic Potential of Bone Marrow Cells by an Interleukin-1-Mediated Inflammatory Response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Quantification of myocardial segmental function in acute and chronic ischemic heart disease and implications for cardiovascular cell therapy trials: a review from the NHLBI-Cardiovascular Cell Therapy Research Network

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Rationale and design for TIME: A phase II, randomized, double-blind, placebo-controlled pilot trial evaluating the safety and effect of timing of administration of bone marrow mononuclear cells after acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

The immune system and cardiac repair.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

6 July 2018

Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3652242

27 October 2018

Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Int

1 reference

https://pubmed.ncbi.nlm.nih.gov/23129008

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1001/JAMA.2012.28726

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34467911&oldid=1739205974"